Render Target: STATIC
Render Timestamp:
4/7/2025, 3:06:32 AM EDT
4/7/2025, 7:06:32 AM UTC
Commit: c91f970ca8df4f527662a05c7bd6e4d03c6fa173
XML generation date: 2025-03-07 13:17:07.593
Product last modified at: 2025-01-01T09:03:36.721Z
Cell Signaling Technology Logo

Basket Updated

0

Items added

1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

NSC-95397 #53455

NSC-95397: Image 1
Chemical structure of NSC-95397.

To Purchase # 53455

Cat. # Size Qty. Price
53455S 5 mg
$125

Product Information

Product Usage Information

NSC-95397 is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.61 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

Storage

Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight 310.4 g/mol
Purity >98%
Molecular Formula C14H14O4S2
CAS 93718-83-3
Solubility Soluble in DMSO at 15 mg/mL or ethanol at 1 mg/mL.

Background

NSC-95397 is a quinone-containing inhibitor of the cdc25 dual-specificity phosphatases responsible for regulating eukaryotic cell entry into mitosis. The primary substrate of cdc25A is CDK2, which allows progression through the G1/S and intra-S checkpoints; cdc25C activates CDK1 to overcome the G2/M checkpoint and allow mitotic entry (1). cdc25 phosphatase inhibition by NSC-95397 varies, with dissociation constants for cdc25A, -B, and -C of Ki = 32 nM, 96 nM, and 40 nM, respectively (2). NSC-95397 treatment of cancer cell lines leads to cell growth inhibition and cell cycle arrest at G2/M (1). Similar growth inhibition was seen in human hepatoma and breast cancer cells (3). Exposure of human erythrocytes to NSC-95397 triggers cell shrinkage, cell membrane scrambling, and eryptosis (4). The dual-specificity phosphatases MAP Kinase phosphatase 1 (MKP1) and MKP3 are likewise inhibited by NSC-95397, with NSC-95397 treatment followed by inhibited proliferation and reduced cell viability in a number of colon cancer cell lines (5,6).
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.